Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 2.2.2024Teva B.V. (TEV-NL-4)95236Sertralin Actavis 100 mg (tbl flm 30x100 mg (blis.PVC/Al))8.1.2024O
 2.2.2024Bristol-Myers Squibb/Pfizer EEIG (BMS-IE-1)08363Eliquis 2,5 mg filmom obalené tablety (tbl flm 20x2,5 mg (blis.PVC/PVDC/Al))12.2.2024Z
 2.2.2024ARDEZ Pharma, spol. s r.o. (ARZ)2436DTedez (cps dur 90x0,5 mg/0,4 mg (fľ.HDPE))5.2.2024O
 2.2.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)3868ESeHCAT 370 kBq tvrdá kapsula (cps dur 1x370 kBq (obal polystyrénový))2.2.2024U
 2.2.2024CHEPLAPHARM Registration GmbH (CEP-2)64306ZYPADHERA 210 mg prášok a rozpúšťadlo na injekčnú suspenziu s predĺženým uvoľňovaním (plu igf 1x210 mg (liek.inj.skl.) +1x3 ml solv.(liek.inj.skl.))31.1.2024O
 2.2.2024CHEPLAPHARM Registration GmbH (CEP-2)64307ZYPADHERA 300 mg prášok a rozpúšťadlo na injekčnú suspenziu s predĺženým uvoľňovaním (plu igf 1x300 mg (liek.inj.skl.) +1x3 ml solv.(liek.inj.skl.))2.2.2024O
 1.2.2024N.V. Organon (ORG-NL)64444SINGULAIR 4 mg granulát (gra por 28x4 mg (vrecko PE/Al/PES))1.2.2024O
 1.2.2024N.V. Organon (ORG-NL)05878Montelukast Organon 10 mg (tbl flm 56x10 mg (blis.Al/Al))1.2.2024O
 1.2.2024Neuraxpharm Bohemia s.r.o. (NUA)2720BRisperidon Farmax 1 mg filmom obalené tablety (tbl flm 60x1 mg (blis.PVC/LDPE/PVDC/A))1.2.2024O
 1.2.2024TAD Pharma GmbH (TPW-D-2)04625Atoridor 80 mg (tbl flm 30x80 mg (blis.OPA/Al/PVC/Al))5.2.2024R
 1.2.2024TAD Pharma GmbH (TPW-D-2)04627Atoridor 80 mg (tbl flm 90x80 mg (blis.OPA/Al/PVC/Al))5.2.2024R
 1.2.2024KRKA, d.d., Novo mesto (KRK-2)23302Sorvasta 10 mg (tbl flm 30x10 mg (blis.OPA/Al/PVC/Al))5.2.2024R
 1.2.2024Novartis Europharm Limited (NEH-IE)03907AZOPT 10 mg/ml, očné suspenzné kvapky (int opu 1x5 ml (fľ.PE))1.2.2024R
 1.2.2024Mylan Ireland Limited (MNY)5331CAripiprazol Mylan 10 mg orodispergovateľné tablety (tbl oro 28x10 mg (blis.PA/Al/PVC/Al/papier/PET-perfor.))1.2.2024R
 1.2.2024Takeda Manufacturing Austria AG (TKM-5)97247KIOVIG 100 mg/ml infúzny intravenózny roztok (sol inf 1x50 ml/5 g (liek.inj.skl.))31.1.2024O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)